Early Success Seen With CAR T-Cell Therapy for SSc

A case series showed that chimeric antigen receptor T-cell therapy targeting CD19 halted the progression of fibrotic organ manifestations in six patients with diffuse cutaneous systemic sclerosis.
Medscape Medical News